ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,710Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 315

$1.13M Total Retail Price of All Prescriptions

Rank: 8 out of 315

471 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Hawaii
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 471 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

19% of this provider’s 471 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 14,469 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Hawaii
AMLODIPINE BESYLATE 885 781 1 2
SIMVASTATIN 788 660 2 1
ALENDRONATE SODIUM 640 571 3 12
METFORMIN HCL 492 397 4 7
LOSARTAN POTASSIUM 485 416 5 4
OMEPRAZOLE 447 356 6 9
LOVASTATIN 414 377 7 8
LISINOPRIL 396 297 8 3
ATORVASTATIN CALCIUM 370 302 9 5
CARVEDILOL 313 256 10 22
HYDROCODONE-ACETAMINOPHEN 312 208 S3 11 19
GLIMEPIRIDE 278 241 12 32
FENOFIBRATE 262 181 13 43
TRAMADOL HCL 262 257 13 59
LEVOTHYROXINE SODIUM 260 225 15 6
CRESTOR 258 204 16 24
CLOPIDOGREL 244 212 17 25
NAMENDA 215 192 18 38
ADVAIR DISKUS 215 195 18 46
ALLOPURINOL 215 174 18 14
MECLIZINE HCL 192 187 21 81
DIOVAN 185 158 22 27
TAMSULOSIN HCL 182 168 23 21
FUROSEMIDE 176 159 24 15
MUPIROCIN 172 105 25 110
DONEPEZIL HCL 170 142 26 28
JANUVIA 167 152 27 31
DILTIAZEM 24HR ER 159 147 28 90
PRAVASTATIN SODIUM 156 139 29 10
PLAVIX 154 135 30 40
RANITIDINE HCL 140 106 31 42
SPIRIVA 140 117 31 74
LEVETIRACETAM 133 80 33 189
GABAPENTIN 133 88 33 37
NIASPAN 122 86 35 103
METOPROLOL TARTRATE 121 98 36 18
HYDROCHLOROTHIAZIDE 119 119 37 16
CEFDINIR 114 100 38 195
LANTUS 105 87 39 113
METOPROLOL SUCCINATE 104 100 40 13
IBUPROFEN 101 89 41 89
CLOBETASOL PROPIONATE 100 92 42 82
NIFEDIAC CC 99 86 43 97
HYDROXYZINE HCL 98 70 R 44 105
ACTONEL 94 80 45 47
BENICAR 93 80 46 80
MELOXICAM 90 86 47 77
POTASSIUM CHLORIDE 89 87 48 36
AMANTADINE 87 73 49 274
LANTUS SOLOSTAR 87 74 49 69
PROAIR HFA 86 60 51 52
EVISTA 85 71 52 48
ZOLPIDEM TARTRATE 80 54 53 29
NIFEDIPINE ER 79 65 54 67
CEPHALEXIN 79 48 54 109
FELODIPINE ER 77 63 56 23
COUMADIN 77 77 56 238
ULORIC 76 69 58 182
ESCITALOPRAM OXALATE 75 66 59 108
JANUMET 75 46 59 83
COLCRYS 74 66 61 85
VESICARE 74 48 61 150
PREDNISONE 73 69 63 41
CELEBREX 72 69 64 34
LABETALOL HCL 69 52 65 125
AVODART 69 69 65 113
CIPROFLOXACIN HCL 69 61 65 58
RISPERIDONE 68 59 68 148
SEROQUEL XR 68 68 68 295
QUETIAPINE FUMARATE 67 52 70 143
MIRTAZAPINE 63 50 71 68
LOSARTAN-HYDROCHLOROTHIAZIDE 62 62 72 17
CARISOPRODOL 62 0 R 72 166
ATELVIA 62 56 72 102
BYSTOLIC 60 60 75 73
LOPERAMIDE 56 52 76 159
DIOVAN HCT 55 38 77 56
PAROXETINE HCL 55 45 77 142
AMLODIPINE BESYLATE-BENAZEPRIL 54 54 79 26
CLOTRIMAZOLE-BETAMETHASONE 54 29 79 132
VERAPAMIL ER 54 51 79 94
GLIPIZIDE ER 53 45 82 55
PANTOPRAZOLE SODIUM 53 51 82 35
AZITHROMYCIN 53 48 82 39
DIGOXIN 51 51 85 45
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.